Posts Tagged ‘Biopsy’

New Guidelines Stir Up Controversy

Posted on: April 12th, 2019 by admin 1 Comment

A paper appeared earlier this week in the Annals of Internal Medicine entitled “Screening for breast cancer in average-risk women: a guidance […]

ABUS vs DBT – Again

Posted on: March 8th, 2019 by admin 2 Comments

The European Congress of Radiology, with a giant octopus in the registration area and a collage of aquatic images, concluded in […]

Thinking Outside of the Globe

Posted on: February 15th, 2019 by admin 3 Comments

Since 1980, the Canadian Space Agency (CSA) has been collaborating with its American counterpart NASA to develop and deploy sophisticated […]

Tomosynthesis vs Ultrasound in Dense Breasts

Posted on: January 11th, 2019 by admin 1 Comment

A research group based at the University of Genoa in Italy is known by its acronym ASTOUND, which stands for Adjunct […]

Looking for a Polar Bear in a Snowstorm

Posted on: December 28th, 2018 by admin 2 Comments

Fifteen years ago, Nancy Cappello’s annual screening mammogram was found to be normal, just as had been reported for the […]

Google Meets Breast Cancer Challenge

Posted on: October 19th, 2018 by admin 3 Comments

Four years ago Google bought a British artificial intelligence (AI) company called DeepMind for half a billion US dollars. The founders studied […]

NCI Launches Plans for 2020

Posted on: September 28th, 2018 by admin 1 Comment

A decade ago, when CapeRay was still being incubated within the University of Cape Town (UCT), we were successful in […]

Predicting the Return of Breast Cancer

Posted on: August 17th, 2018 by admin

Clinicians do not currently have a reliable way to predict which patients treated for hormone receptor-positive (HR+) breast cancer run […]

POCUS Gathers Momentum

Posted on: July 13th, 2018 by admin 2 Comments

In the past week two companies – Hologic from the USA and Healcerion from South Korea – have announced FDA […]

In Defence of Screening

Posted on: January 19th, 2018 by admin 1 Comment

As highlighted in these weekly blogs over the past six years, there have been well-publicised efforts to undermine the benefits […]